AUTOIMMUNE HEMOLYTIC ANEMIA
Clinical trials for AUTOIMMUNE HEMOLYTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE HEMOLYTIC ANEMIA trials appear
Sign up with your email to follow new studies for AUTOIMMUNE HEMOLYTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested for stubborn blood disorder
Disease control Not yet recruitingThis study is testing an oral medication called Linprixel for adults with autoimmune hemolytic anemia that has come back or not responded to at least two prior treatments. Over 12 weeks, doctors will adjust the dose based on how well the patient responds and monitor for side effe…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Experimental cell therapy tested for Tough-to-Treat blood disorder
Disease control Not yet recruitingThis early-stage study is testing the safety and initial effectiveness of a new cell therapy called YTS109 for adults with severe autoimmune hemolytic anemia (AIHA) who have not improved after at least three other treatments. The study will enroll about 13 participants to find a …
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Experimental cell therapy offers hope for patients exhausting all treatment options
Disease control Not yet recruitingThis early-stage study is testing whether a new cell therapy called YTS109 is safe and might help adults with autoimmune hemolytic anemia who have not improved after trying at least three other treatments. Researchers will give patients different doses of the modified cells to fi…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE1 • Sponsor: China Immunotech (Beijing) Biotechnology Co., Ltd. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New drug trial targets root cause of stubborn blood disorder
Disease control Not yet recruitingThis study is testing an experimental drug called enatumab for adults with a specific type of autoimmune hemolytic anemia (wAIHA) that has come back or not improved after at least two standard treatments. The drug works by guiding the body's own immune T-cells to attack the abnor…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE2 • Sponsor: Bing Han • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC